Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings

Privia Health (PRVA) reported $460.9 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.6%. EPS of $0.03 for the same period compares to $0.02 a year ago.The reported revenue represents a surprise of +10.37% over the Zacks Consensus Estimate of $417.6 million. With the consensus EPS estimate being $0.06, the EPS surprise was -50.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Privia Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Practice Collections: $792.50 million versus $719.81 million estimated by seven analysts on average. Care Margin: $107.70 million compared to the $101.70 million average estimate based on six analysts. Platform Contribution: $53.20 million versus the six-analyst average estimate of $48.89 million. Implemented Providers (as of end of period): 4,789 compared to the 4,743 average estimate based on three analysts. Value-Based Care Attributed Lives (as of end of period): 1.26 million versus 1.23 million estimated by three analysts on average. View all Key Company Metrics for Privia Health here>>>Shares of Privia Health have returned +6.9% over the past month versus the Zacks S&P 500 composite's -2.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Privia Health Group, Inc. (PRVA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks